Literature DB >> 9404236

Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group.

.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9404236

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  20 in total

1.  Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in mice.

Authors:  P J Jenks; R L Ferrero; J Tankovic; J M Thiberge; A Labigne
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 2.  Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.

Authors:  Susan M Cheer; Amitabh Prakash; Diana Faulds; Harriet M Lamb
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.

Authors:  H R Koelz; R Arnold; M Stolte; M Fischer; A L Blum
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

4.  Frequent association between alteration of the rdxA gene and metronidazole resistance in French and North African isolates of Helicobacter pylori.

Authors:  J Tankovic; D Lamarque; J C Delchier; C J Soussy; A Labigne; P J Jenks
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

5.  Helicobacter pylori infection in bleeding peptic ulcer patients after non-steroidal antiinflammatory drug consumption.

Authors:  Francesco Manguso; Elisabetta Riccio; Germana de Nucci; Maria Luisa Aiezza; Gerardino Amato; Linda Degl'Innocenti; Maria Maddalena Piccirillo; Gianfranco De Dominicis; Tara Santoro; Elena Trimarco; Antonio Balzano
Journal:  World J Gastroenterol       Date:  2011-10-28       Impact factor: 5.742

6.  Differentiation of metronidazole-sensitive and -resistant clinical isolates of Helicobacter pylori by immunoblotting with antisera to the RdxA protein.

Authors:  S R Latham; R J Owen; N C Elviss; A Labigne; P J Jenks
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  Comparison of three stool antigen tests for Helicobacter pylori detection.

Authors:  J Andrews; B Marsden; D Brown; V S Wong; E Wood; M Kelsey
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

8.  Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.

Authors:  Yung-Chih Lai; Teh-Hong Wang; Shih-Hung Huang; Sien-Sing Yang; Chi-Hwa Wu; Tzen-Kwan Chen; Chia-Long Lee
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

9.  Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis.

Authors:  Marilena Durazzo; Floriano Rosina; Alberto Premoli; Enrico Morello; Sharmila Fagoonee; Rosaria Innarella; Enrico Solerio; Rinaldo Pellicano; Mario Rizzetto
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

10.  Screening for metronidazole-resistance associated gene fragments of H pylori by suppression subtractive hybridization.

Authors:  Ai-Qing Li; Ning Dai; Jie Yan; Yong-Liang Zhu
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.